Rapalogs are a new class of medications that slow the aging of every cell with a nucleus in the body — every organ and tissue — by improving cellular functioning to levels seen in our 20s.
Several rapalogs are in late-stage clinical trials. Rapamycin is currently the only rapalog anti-aging prescription medication on the market and has been FDA-approved for more than 20 years. It has been shown to improve health span by 15–30% with clear improvement on multiple aging biomarkers (telomere length, cancer prevention, cognitive and physical function).
